Thu, April 22, 2021
Wed, April 21, 2021
Tue, April 20, 2021
Mon, April 19, 2021
Fri, April 16, 2021
Thu, April 15, 2021

Matthew Harrison Maintained (BIIB) at Buy with Decreased Target to $343 on, Apr 19th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-343-on-apr-19th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $351 to $343 on, Apr 19th, 2021.

Matthew has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $245 on, Monday, April 12th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $268 on, Wednesday, February 17th, 2021


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $305 on, Thursday, February 4th, 2021
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $338 on, Thursday, February 4th, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $380 on, Thursday, February 4th, 2021

Publication Contributing Sources